Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gadoquatrane PK and Safety in Pediatric Contrast-Enhanced MRI
CTR20232705Phase 3Completed
- Sponsor
- ---
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gadoquatrane in imaging indication (various pediatric clinical conditions requiring contrast-enhanced magnetic resonance imaging), sponsored by ---. Started Sep 2023; status: completed.
02
Drugs
gadoquatrane
03
Conditions
imaging indication (various pediatric clinical conditions requiring contrast-enhanced magnetic resonance imaging)
Beyond the preview
Go deeper on CTR20232705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232705.